António Jorge Ferreira

Prof. Dr. António Jorge Ferreira


Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 January 2013 in Pulmonology
Verified
Journal Article
Open access
AFAntónio Jorge Ferreira
António Jorge Ferreira
JCJ. Cemlyn-Jones
J. Cemlyn-Jones
CCC. Robalo Cordeiro
C. Robalo Cordeiro
The recently emergent field of Nanotechnology involves the production and use of structures at the nanoscale. Research at atomic, molecular or macromolecular levels, has led to new materials, systems and structures on a scale consisting of particles less than 100 nm and showing unique and unusual physical, chemical and biological properties, which has enabled new applications in diverse fields, creating a multimillion-dollar high-tech industry. Nanotechnologies have a wide variety of uses from nanomedicine, consumer goods, electronics, communications and computing to environmental applications, efficient energy sources, agriculture, water purification, textiles, and aerospace industry, among many others. The different characteristics of nanoparticles such as size, shape, surface charge, chemical properties, solubility and degree of agglomeration will determine their effects on biological systems and human health, and the likelihood of respiratory hazards. There are a number of new studies about the potential occupational and environmental effects of nanoparticles and general precautionary measures are now fully justified. Adverse respiratory effects include multifocal granulomas, peribronchial inflammation, progressive interstitial fibrosis, chronic inflammatory responses, collagen deposition and oxidative stress. The authors present an overview of the most important studies about respiratory nanotoxicology and the effects of nanoparticles and engineered nanomaterials on the respiratory system.

1 October 2010 in Environment International
Verified
Journal Article
Closed access
Ana Isabel MirandaAna Isabel Miranda
Ana Isabel Miranda
VMVera Martins
Vera Martins
PCPedro Cascão
Pedro Cascão
JAJorge Amorim
Jorge Amorim
JVJoana Valente
Joana Valente
LPLuís Paulo Pita
Luís Paulo Pita

12 July 2012 in Journal of Toxicology and Environmental Health, Part A
Verified
Journal Article
Closed access
Ana Isabel MirandaAna Isabel Miranda
Ana Isabel Miranda
VMVera Martins
Vera Martins
PCPedro Cascão
Pedro Cascão
JAJorge Amorim
Jorge Amorim
JVJoana Valente
Joana Valente
RORoger Ottmar
Roger Ottmar
Smoke from forest fires contains significant amounts of gaseous and particulate pollutants. Firefighters exposed to wildland fire smoke can suffer from several acute and chronic adverse health effects. Consequently, exposure data are of vital importance for the establishment of cause/effect relationships between exposure to smoke and firefighter health effects. The aims of this study were to (1) characterize the relationship between wildland smoke exposure and medical parameters and (2) identify health effects pertinent to wildland forest fire smoke exposure. In this study, firefighter exposure levels of carbon monoxide (CO), nitrogen dioxide (NO2), and volatile organic compounds (VOC) were measured in wildfires during three fire seasons in Portugal. Personal monitoring devices were used to measure exposure. Firefighters were also tested for exhaled nitric oxide (eNO) and CO before and after their firefighting activities. Data indicated that exposure levels during firefighting activities were beyond limits recommended by the Occupational Exposure Standard (OES) values. Medical tests conducted on the firefighters also indicated a considerable effect on measured medical parameters, with a significant increase in CO and decrease in NO in exhaled air of majority of the firefighters.

1 November 2021 in International Journal of Chronic Obstructive Pulmonary Disease
Verified
Journal Article
Open access
PDF file
JCJoão Cardoso
João Cardoso
AFAntónio Jorge Ferreira
António Jorge Ferreira
MGMiguel Guimaraes
Miguel Guimaraes
AOAna Sofia Oliveira
Ana Sofia Oliveira
PSPaula Simão
Paula Simão
MSMaria Sucena
Maria Sucena
The well-recognized individual heterogeneity within COPD patients has led to a growing interest in greater personalization in the approach of these patients. Thus, the treatable traits strategy has been proposed as a further step towards precision medicine in the management of chronic airway disease, both in stable phase and acute exacerbations. The aim of this paper is to perform a critical review on the treatable traits strategy and propose a guide to approach COPD patients in the light of this new concept. An innovative stepwise approach is proposed – a multidisciplinary model based on two distinct phases, with the potential to be implemented in both primary care and hospital settings. The first phase is the initial and focused assessment of a selected subset of treatable traits, which should be addressed in all COPD patients in both settings (primary care and hospital). As some patients may present with advanced disease at diagnosis or may progress despite this initial treatment requiring a more specialized assessment, they should progress to a second phase, in which a broader approach is recommended. Beyond stable COPD, we explore how the treatable traits strategy may be applied to reduce the risk of future exacerbations and improve the management of COPD exacerbations. Since many treatable traits have already been related to exacerbation risk, the strategy proposed here represents an opportunity to be proactive. Although it still lacks prospective validation, we believe this is the way forward for the future of the COPD approach.

1 October 2007 in Seminars in Respiratory and Critical Care Medicine
Verified
Journal Article
Closed access
CCCarlos Robalo Cordeiro
Carlos Robalo Cordeiro
JJJessica Cemlyn Jones
Jessica Cemlyn Jones
TATiago Alfaro
Tiago Alfaro
AFAntónio Jorge Ferreira
António Jorge Ferreira
Occupational lung diseases (OLDs) are related to the exposure and inhalation of organic, inorganic, and synthetic particles, fumes, gases, or infectious agents. From the long list of OLDs this article focuses the discussion on bronchoalveolar lavage (BAL) in parenchymal immunoinflammatory conditions, such as hypersensitivity pneumonitis (HP) and pneumoconiosis. Several antigens may cause HP, including products of plant or animal origin, aerosolized microorganisms, and organic chemicals. BAL is used not only to assess the pathogenesis of these diseases but also to identify the typical pattern of intense lymphocytic alveolitis, usually with a CD4:CD8 ratio below normal and frequently with the presence of mast cells, plasma cells, and foamy macrophages. Pneumoconioses are chronic interstitial lung diseases caused by the inhalation of mineral and metallic inorganic particles/dusts in an occupational setting, showing a decreasing prevalence in recent years. BAL is a useful tool not only to express the complex pathogenic mechanisms of these entities but also in excluding other diagnoses and causes of alveolitis, and to document specific exposures, such as the identification of asbestos bodies (ABs) in asbestosis or the proliferative response of BAL lymphocytes to beryllium in chronic beryllium disease (CBD).

31 August 2015 in Acta Medica Portuguesa
Verified
Journal Article
Open access
PDF file
ISInês Sanches
Inês Sanches
FTFátima Teixeira
Fátima Teixeira
JSJosé Moutinho dos Santos
José Moutinho dos Santos
AFAntónio Jorge Ferreira
António Jorge Ferreira
Introduction: To evaluate sleep deprivation and its effects on young physicians in relation to concentration capacity and psychomotor performance.Material and Methods: Eighteen physicians aged 26 - 33 years were divided into 2 groups: non-sleep deprived group (with no night work) and sleep deprived group (minimum 12 hour of night work/week). We applied Pittsburgh Sleep Quality Index to screen the presence of sleep pathology and Epworth Sleepiness Scale to evaluate subjective daytime sleepiness; we used actigraphy and sleep diary to assess sleep hygiene and standard sleep-wake cycles. To demonstrate the effects of sleep deprivation, we applied Toulouse-Piéron’s test (concentration test) and a battery of three reaction time tasks after the night duty.Results: Sleep deprived group had higher daytime sleepiness on Epworth Sleepiness Scale (p < 0.05) and during week sleepdeprivation was higher (p < 0.010). The mean duration of sleep during the period of night duty was 184.2 minutes to sleep deprived group and 397.7 minutes to non-sleep deprived group (p < 0.001). In the Toulouse-Piéron´s test, the sleep deprived group had more omissions (p < 0.05) with a poorer result in concentration (p < 0.05). Psychomotor tests that evaluated response to simple stimuli revealed longer response latency (p < 0.05) and more errors (p < 0.05) in Sleep deprived group; in reaction to instruction test the sleepdeprived group showed worse perfection index (p < 0.05); in the fine movements test there was no statistically significant difference between the groups.Discussion: Acute sleep deprivation resulting from nocturnal work in medical professions is associated with a reduction in attention and concentration and delayed response to stimuli. This may compromise patient care as well as the physician’s health and quality of life.Conclusion: It is essential to study the effects of acute sleep deprivation on the cognitive abilities and performance of healthprofessionals.